SYBLEU INC (SYBE)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -149.18 Thousand USD | -164.63% |
| 2021 | -56.37 Thousand USD | 36.12% |
| 2020 | -88.25 Thousand USD | -90.58% |
| 2019 | -46.3 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -24.62 Thousand USD | -393.29% |
| 2023 Q3 | -126.72 Thousand USD | -15.37% |
| 2023 Q4 | -15.16 Thousand USD | 88.04% |
| 2023 Q2 | -109.84 Thousand USD | -346.06% |
| 2022 Q3 | -9080.00 USD | 0.0% |
| 2022 FY | -149.18 Thousand USD | -164.63% |
| 2022 Q4 | -4992.00 USD | 45.02% |
| 2021 FY | -56.37 Thousand USD | 36.12% |
| 2020 FY | -88.25 Thousand USD | -90.58% |
| 2019 FY | -46.3 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -5.871% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 78.284% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | 13.019% |
| CytoDyn Inc. | -18.05 Million USD | 99.174% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 99.747% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -20538.895% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 91.787% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 97.043% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -398.064% |
| Reve Technologies, Inc. | -181.48 Thousand USD | 17.8% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Cognition Inc. | -9.7 Million USD | 98.463% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 99.731% |
| SQZ Biotechnologies Company | -75.82 Million USD | 99.803% |
| Resverlogix Corp. | -12.74 Million USD | 98.83% |
| Neon Bloom, Inc. | -389.57 Thousand USD | 61.706% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 101.531% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 93.924% |
| Mesoblast Limited | -84.14 Million USD | 99.823% |
| GB Sciences, Inc. | -1.42 Million USD | 89.498% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | 78.284% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 99.164% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 95.619% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 97.756% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 95.291% |
| ContraFect Corporation | -56.88 Million USD | 99.738% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 94.577% |
| BioStem Technologies, Inc. | -7.77 Million USD | 98.082% |
| LadRx Corporation | -3.82 Million USD | 96.098% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 99.06% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 86.668% |
| CSL Limited | 3.7 Billion USD | 100.004% |
| Biomind Labs Inc. | -1 Million USD | 85.224% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 83.983% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 100.182% |
| Nascent Biotech, Inc. | -2.22 Million USD | 93.31% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 99.792% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 103.035% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 104.214% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 90.288% |
| Marizyme, Inc. | -34.08 Million USD | 99.562% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 98.213% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | 73.584% |
| Zenith Capital Corp. | -8.94 Million USD | 98.332% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 94.767% |
| Halberd Corporation | -75.05 Thousand USD | -98.774% |
| Genus plc | 6.4 Million USD | 102.331% |
| Pharming Group N.V. | -4.87 Million USD | 96.943% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 92.49% |
| IMV Inc. | -38.67 Million USD | 99.614% |
| Affymax, Inc. | -15.04 Million USD | 99.009% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 85.711% |
| Enzolytics Inc. | -2.14 Million USD | 93.058% |
| argenx SE | -425.04 Million USD | 99.965% |
| AVAX Technologies, Inc. | 6.69 Million USD | 102.229% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 89.359% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 88.829% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | 96.018% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -492.69% |
| Cell Source, Inc. | -4.32 Million USD | 96.551% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | 69.118% |
| Q BioMed Inc. | -3.44 Million USD | 95.67% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 96.48% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 88.123% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 94.322% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 96.725% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 99.729% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 94.858% |
| Rebus Holdings, Inc. | -664 Thousand USD | 77.533% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 84.84% |
| Skye Bioscience, Inc. | -13.67 Million USD | 98.909% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 91.998% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 92.559% |
| ONE Bio Corp. | 13.68 Million USD | 101.09% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 92.281% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 86.738% |
| Agentix Corp. | -1.37 Million USD | 89.125% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 94.89% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 90.554% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -756.323% |
| Kadimastem Ltd | -3.04 Million USD | 95.093% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | 43.001% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 64.094% |
| NovAccess Global Inc. | -2.46 Million USD | 93.952% |
| Itoco Inc. | -919.14 Thousand USD | 83.77% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | 32.215% |
| Qrons Inc. | -643.67 Thousand USD | 76.824% |
| Mobile Lads Corp. | -554.55 Thousand USD | 73.099% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.964% |
| International Stem Cell Corporation | -663 Thousand USD | 77.499% |
| Bioxytran, Inc. | -3.82 Million USD | 96.095% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -183.397% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -633.432% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 99.589% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 90.78% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | 79.726% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 95.205% |
| Neutra Corp. | -229.48 Thousand USD | 34.994% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 99.149% |
| PureTech Health plc | -146.19 Million USD | 99.898% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 99.306% |
| IXICO plc | -1.43 Million USD | 89.619% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 98.428% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.878% |
| CSL Limited | 3.81 Billion USD | 100.004% |
| Cellectis S.A. | -108.85 Million USD | 99.863% |